Clarivate have released their ‘Drugs to Watch 2023’ listing – the report includes information on the key trends, such as:
- The growing market in mainland China
- The impending loss of exclusivity of HUMIRA
- COVID-19 vaccines and therapies
- Personalized medicines’ move from promise to reality
- How sustainable goals encourage innovative solutions
Download the report from: https://clarivate.com/drugs-to-watch/drugs-to-watch-listing/